These data identify that the absolute decrease in expression due to BRD4 focal deletions remains significant even when controlling for tumor type and copy number, and that the extent to which absolute BRD4 expression levels are inherently oncogenic or toxic is highly dependent on tissue of origin. The gene discussed is BRD4; the disease is neoplasm.